BIT 2.70% 3.8¢ biotron limited

$200 billion deal, page-20

  1. 7,914 Posts.
    lightbulb Created with Sketch. 980
    To find a fair price we could also look at recent Pharma Deals

    Merck & Co bought out Prometheus for $10.8 billion USD ($17.18 Billion AUD)
    picking up a promising experimental treatment for ulcerative colitis and Crohn's disease and building up its presence in immunology.

    https://www.reuters.com/markets/dea...cquire-prometheus-biosciences-wsj-2023-04-16/

    Ulcerative colitis and Crohn's disease have a combined market of $17.5 Billion a Year.

    BIT in comparison can treat much higher Billion a year markets,
    So should be valued much higher....IMO....

    (Something in the $100 Billion to $200 Billion range seems reasonable.)

    Another recent Pharma Purchase was:
    In March Pfizer struck a $43 billion USD ($67.65 Billion AUD) deal
    to acquire Seagen Inc (SGEN.O) and its targeted cancer therapies.

    Anyhow here's a list of Big Pharma Co's by Market Cap:
    https://companiesmarketcap.com/pharmaceuticals/largest-pharmaceutical-companies-by-market-cap/

    (note: their market Caps are in USD)
    Last edited by $$$$$$$$: 26/10/23
 
watchlist Created with Sketch. Add BIT (ASX) to my watchlist
(20min delay)
Last
3.8¢
Change
0.001(2.70%)
Mkt cap ! $34.28M
Open High Low Value Volume
3.7¢ 4.0¢ 3.7¢ $68.85K 1.794M

Buyers (Bids)

No. Vol. Price($)
2 150000 3.7¢
 

Sellers (Offers)

Price($) Vol. No.
4.0¢ 349950 3
View Market Depth
Last trade - 15.10pm 28/06/2024 (20 minute delay) ?
BIT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.